| Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY. 12 clinical trial A Vijenthira, X Li, M Crump, AE Hay, L Shepherd, RM Meyer, M Djurfeldt, ... Leukemia & Lymphoma, 1-8, 2024 | | 2024 |
| Detaillierte Analyse von operativen Parametern im Rahmen der internationalen Phase III-Studie AGO-OP. 8/CCTG CX. 5/SHAPE F Trillsch, S Mahner, B Krämer, J Radosa, A Burges, B Schmalfeldt, ... Geburtshilfe und Frauenheilkunde 84 (06), FV05, 2024 | | 2024 |
| Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA. 27 Postmenopausal Breast Cancer Trial of … JAW Chapman, J Bayani, S SenGupta, JMS Bartlett, T Piper, MA Quintayo, ... Journal of Clinical Oncology, JCO. 24.00835, 2024 | | 2024 |
| Adjunctive statistical standardization of quantitated adjuvant ER and PgR in CCTG MA. 27. JAW Chapman, J Bayani, S SenGupta, JMS Battlett, T Piper, MA Quintayo, ... Journal of Clinical Oncology 42 (16_suppl), 567-567, 2024 | | 2024 |
| Canadian cancer trials group LY. 17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B … DA Stewart, J Kuruvilla, D Lee, JJ Dudebout, N Chua, JF Larouche, ... British Journal of Haematology, 2024 | 1 | 2024 |
| Abstract PO3-02-05: Racial and Ethnic Differences in Clinical Outcomes among North American Patients with Hormone Receptor-Positive, HER2-negative, Early Breast Cancer in the … O Kantor, O Fayanju, A Dueck, M Gnant, H Burstein, M Goetz, C Isaacs, ... Cancer Research 84 (9_Supplement), PO3-02-05-PO3-02-05, 2024 | | 2024 |
| Abstract PO1-27-10: Adjunctive statistical standardization of quantitated machine image analysis of Estrogen and Progesterone Receptors: CCTG MA. 27 trial JA Chapman, J Bayani, S SenGupta, JMS Bartlett, T Piper, MA Quintayo, ... Cancer Research 84 (9_Supplement), PO1-27-10-PO1-27-10, 2024 | | 2024 |
| 738 Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer–analysis of the international CCTG CX. 5/SHAPE phase III trial S Mahner, F Trillsch, J Kwon, SE Ferguson, P Bessette, G Ferron, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | 1 | 2024 |
| 256 Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer from the CCTG CX. 5 ‘SHAPE’phase III clinical trial JS Kwon, M Plante, S Ferguson, H Mctaggart-Cowan, V Samouëlian, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| Simple versus radical hysterectomy in women with low-risk cervical cancer M Plante, JS Kwon, S Ferguson, V Samouëlian, G Ferron, A Maulard, ... New England Journal of Medicine 390 (9), 819-829, 2024 | 35 | 2024 |
| Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer-Analysis of the international CCTG CX. 5/SHAPE phase III trial S Mahner, F Goffin, F Trillsch, J Kwon, S Ferguson, P Bessette, G Ferron, ... 25th European Congress on Gynecological Oncologye,, 2024 | | 2024 |
| Radical versus simple hysterectomy in women with low-risk cervical cancer M Plante, J Kwon, S Fergussen, V Samouëlian, G Ferron, A Maulard, ... New England Journal of Medicine, 2024 | | 2024 |
| Effect of metformin versus placebo on new primary cancers in Canadian Cancer Trials Group MA. 32: a secondary analysis of a phase III randomized double-blind trial in early … PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan, M Ennis, J Lemieux, ... Journal of Clinical Oncology 41 (35), 5356-5362, 2023 | 7 | 2023 |
| The New NCI Precision Medicine Trials LN Harris, CD Blanke, HP Erba, JM Ford, RJ Gray, ML LeBlanc, ... Clinical Cancer Research 29 (23), 4728-4732, 2023 | 1 | 2023 |
| Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial G Pfeiler, D Hlauschek, EL Mayer, C Deutschmann, S Kacerovsky-Strobl, ... Journal of Clinical Oncology 41 (33), 5118-5130, 2023 | 8 | 2023 |
| Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets S El Kababji, N Mitsakakis, X Fang, AA Beltran-Bless, G Pond, ... JCO Clinical Cancer Informatics 7, e2300116, 2023 | 4 | 2023 |
| # 461 Patient reported outcomes from CCTG CX. 5 (SHAPE): randomized trial comparing radical hysterectomy (RH) and pelvic node dissection (PND) vs simple hysterectomy (SH) and … S Ferguson, M Plante, D Tu, J Kwon, V Samouelian, G Ferron, A Maulard, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | 1 | 2023 |
| # 142 An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in … M Plante, J Kwon, S Ferguson, V Samouëlian, G Ferron, A Maulard, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | 1 | 2023 |
| Relapse timing is associated with distinct evolutionary dynamics in diffuse large B-cell lymphoma LK Hilton, HS Ngu, B Collinge, K Dreval, S Ben-Neriah, CK Rushton, ... Journal of Clinical Oncology 41 (25), 4164-4177, 2023 | 14 | 2023 |
| Contact days associated with cancer treatments in the CCTG LY. 12 Trial A Gupta, AE Hay, M Crump, MS Djurfeldt, L Zhu, MC Cheung, ... The Oncologist 28 (9), 799-803, 2023 | 9 | 2023 |
